Andlauer Healthcare Group (AND) Scheduled to Post Quarterly Earnings on Thursday

Andlauer Healthcare Group (TSE:AND – Get Rating) is set to announce its earnings results after the market closes on Thursday, March 2nd.

Andlauer Healthcare Group Stock Performance

→ 3 Secrets To Consistent Trading Success (From Vantage Point)pixel

TSE AND opened at C$47.31 on Thursday. The company’s 50 day moving average is C$47.28 and its 200-day moving average is C$49.62. The company has a quick ratio of 1.66, a current ratio of 1.76 and a debt-to-equity ratio of 39.44. The firm has a market cap of C$863.88 million, a P/E ratio of 18.13 and a beta of 0.65. Andlauer Healthcare Group has a 12-month low of C$37.57 and a 12-month high of C$55.97.

Andlauer Healthcare Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, January 16th. Investors of record on Friday, December 30th were issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.59%. The ex-dividend date was Thursday, December 29th. Andlauer Healthcare Group’s dividend payout ratio (DPR) is presently 10.73%.

Insiders Place Their Bets

In other Andlauer Healthcare Group news, Senior Officer Stephen Barr sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, December 29th. The shares were sold at an average price of C$48.50, for a total value of C$242,500.00. Following the completion of the transaction, the insider now owns 20,498 shares of the company’s stock, valued at approximately C$994,153. Corporate insiders own 1.82% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on AND shares. National Bankshares upped their target price on shares of Andlauer Healthcare Group from C$59.00 to C$60.00 and gave the stock an “outperform” rating in a report on Thursday, November 10th. Eight Capital set a C$62.00 target price on shares of Andlauer Healthcare Group and gave the stock a “buy” rating in a report on Tuesday, January 17th. CIBC decreased their target price on shares of Andlauer Healthcare Group from C$59.00 to C$54.00 and set a “neutral” rating on the stock in a report on Wednesday, January 18th. Royal Bank of Canada cut their price target on shares of Andlauer Healthcare Group from C$52.00 to C$47.00 in a research note on Tuesday, January 17th. Finally, Scotiabank boosted their price target on shares of Andlauer Healthcare Group from C$53.00 to C$55.00 in a research note on Monday, January 23rd. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to, Andlauer Healthcare Group presently has a consensus rating of “Hold” and an average target price of C$57.14.

Andlauer Healthcare Group Company Profile

(Get Rating)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Further Reading

Earnings History for Andlauer Healthcare Group (TSE:AND)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Andlauer Healthcare Group, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Andlauer Healthcare Group wasn’t on the list.

While Andlauer Healthcare Group currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover


Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Demand & Supply Associate Manager
Next post Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference